Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nathaniel E. David currently holds 10,000 shares of Unity Biotechnology, Inc. (UBX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nathaniel E. David has been a net seller of UBX stock. They have purchased $28.5K and sold $12.5M worth of shares.
Nathaniel E. David's most recent insider trade was on Jun 21, 2024, when they sold 10,000 shares at $0.00 per share.
Nathaniel E. David serves as Executive at Unity Biotechnology, Inc. (UBX). They have executed 60 insider transactions totaling $12.5M over their tenure at the company.
Nathaniel E. David holds the position of Executive at Unity Biotechnology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Nathaniel E. David has shown a selling trading pattern, with $28.5K in total purchases and $12.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nathaniel E. David was on Dec 16, 2020, when they sold $8.9M worth of UBX shares. This transaction involved 1,700,000 shares at $5.24 per share.
Nathaniel E. David currently owns 10,000 shares of Unity Biotechnology, Inc. (UBX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nathaniel E. David's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nathaniel E. David has 60 Form 4 filings on record as an insider at Unity Biotechnology, Inc..
Set alerts for Nathaniel E. David and 40,000+ other insiders.